HPLC vs mass spec vs amino acid analysis — what each test proves
A practical guide to the three peptide QC methods, what each can prove and disprove, and why a complete QC profile requires all three.
The three peptide QC methods answer different questions and cannot substitute for one another. HPLC measures how pure the material is. Mass spectrometry confirms it is the right molecule. Amino acid analysis measures how much actual peptide the vial contains. A complete Certificate of Analysis carries all three.
By the Bench Grade Research Team ·
Three analytical methods dominate peptide quality control: high-performance liquid chromatography (HPLC), mass spectrometry (MS), and amino acid analysis (AAA). They are not interchangeable. Each method answers a different question, and a vendor that reports only one of them on its COA is publishing an incomplete quality story. This guide explains what each method can prove, what each cannot prove, and how to read a COA that reports all three.
HPLC — how pure is it?
HPLC separates compounds in a mixture based on their interaction with a stationary phase (typically a C18 reversed-phase column) and an eluent gradient. UV-absorbing peaks come off the column at characteristic retention times. The integrated area under each peak, divided by the total integrated area, gives the area-percent value most COAs report.
- What HPLC proves: the relative abundance of UV-absorbing species in the sample. If the target peak is 99% of total integrated area, then 99% of the UV-detectable material is one compound.
- What HPLC does not prove: that the 99% peak is the peptide you ordered. Two different peptides can have nearly identical retention times. HPLC alone cannot confirm identity.
- What HPLC does not capture: UV-inactive impurities like salt counter-ions, water, residual solvents (DMF, acetonitrile), and inorganic ash. These can account for 15–25% of vial mass on a TFA-salt peptide and never appear in the chromatogram.
Mass spectrometry — is it the right molecule?
Mass spectrometry ionizes the analyte and separates ions by mass-to-charge ratio (m/z). For peptides, the two common ionization methods are electrospray ionization (ESI) and matrix-assisted laser desorption ionization (MALDI). Both produce a spectrum where the observed mass should match the theoretical mass calculated from the peptide's amino acid sequence.
- What MS proves: the molecular weight of the peptide in the vial matches the theoretical mass of the sequence on the label. For a peptide ordered at 1,058.2 Da theoretical, an observed mass of 1,058.3 Da is confirmation; 1,030.2 Da (i.e. one fewer alanine) is a different peptide.
- What MS does not prove: that the peptide is pure. The mass spectrometer can confirm the identity of the dominant species but is not the right tool for quantifying impurity ratios — that's HPLC's job.
- What MS adds beyond HPLC: identity verification. The right interpretation of a complete QC profile is "HPLC says it's 99% one compound, and MS says that one compound has the molecular weight we expected."
Amino acid analysis — how much actual peptide?
Amino acid analysis (AAA) hydrolyzes the peptide into its constituent amino acids and quantifies each one chromatographically. By measuring the absolute amount of each amino acid against an internal standard, AAA produces a peptide-content-by-mass value — the actual milligrams of peptide present per milligram of lyophilized vial mass.
- What AAA proves: the actual peptide content of the vial, separated from counter-ion mass, water, and other non-peptide material.
- What AAA does not prove: that the amino acids are in the right order. AAA destroys the sequence by hydrolyzing it. A scrambled-sequence peptide would give the same AAA profile as the correct sequence.
- Why AAA matters in practice: a peptide reported at 99% HPLC area might still be only 78% actual peptide by mass if the supplier did not perform AAA and you are reading the TFA salt form's vial mass as if it were all peptide. This is the most common source of dosing-equivalent calculation errors in lab work.
How they fit together on a complete COA
| Method | Proves | Does not prove |
|---|---|---|
| HPLC | Relative purity (area %) | Identity, mass content |
| MS | Identity (molecular weight match) | Purity, mass content |
| AAA | Net peptide content by mass | Sequence order, purity ratio |
A peptide COA that reports only HPLC says "some compound is 99% of the sample." A COA that reports HPLC + MS says "the peptide we shipped is 99% of the sample." A COA that reports HPLC + MS + AAA says "the peptide we shipped is 99% of the UV-detectable sample, has the correct molecular weight, and 92% of the vial mass is actual peptide." The third version is the only one that supports research-context mass calculations.
What to ask a peptide supplier
- Do you report HPLC area % AND peptide content by mass on your COA? (If only HPLC: incomplete.)
- Is mass spectrometry confirmation included with both theoretical and observed mass? (If only theoretical: not actually verified.)
- Is the analyzing laboratory independent from the synthesizer? (If the same: weaker signal.)
- Is the COA lot-specific, with the lot number matching the vial label? (If not: no traceability.)
What Bench Grade Peptides publishes
Every per-lot COA we publish at benchgradepeptides.com/coa includes HPLC area % with the integrated chromatogram embedded, ESI-MS with theoretical and observed masses, and AAA-derived peptide content by mass. The analyzing laboratory is named on the COA and is independent from the manufacturing facility. The lot number on the document matches the lot number printed on the vial label — and is scannable from the QR on the vial.
References
Primary literature for the compounds discussed above. Links open the record on PubMed.
- Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2) Davies M, et al. Lancet. 2021. PMID 33667417 → · summary
- Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes Frías JP, et al. N Engl J Med. 2021. PMID 34170647 → · summary
- Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity (STEP 3) Wadden TA, et al. JAMA. 2021. PMID 33625476 → · summary
- Once-Weekly Semaglutide in Adults with Overweight or Obesity Wilding JPH, et al. N Engl J Med. 2021. PMID 33567185 → · summary
- BPC 157 and Standard Angiogenic Growth Factors. Gastrointestinal Tract Healing, Lessons from Tendon, Ligament, Muscle and Bone Healing Sikiric P, et al. Curr Pharm Des. 2018. PMID 29998800 → · summary
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes Marso SP, et al. N Engl J Med. 2016. PMID 27295427 → · summary
- Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes Marso SP, et al. N Engl J Med. 2016. PMID 27633186 → · summary
- A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management Pi-Sunyer X, et al. N Engl J Med. 2015. PMID 26132939 → · summary
Primary sources
- Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2)Lancet · 2021
- Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 DiabetesN Engl J Med · 2021
- Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity (STEP 3)JAMA · 2021
- Once-Weekly Semaglutide in Adults with Overweight or ObesityN Engl J Med · 2021
- BPC 157 and Standard Angiogenic Growth Factors. Gastrointestinal Tract Healing, Lessons from Tendon, Ligament, Muscle and Bone HealingCurr Pharm Des · 2018
- Liraglutide and Cardiovascular Outcomes in Type 2 DiabetesN Engl J Med · 2016
Frequently asked questions
- Can HPLC alone confirm a peptide's identity?
- No. HPLC measures purity — what fraction of the material elutes as the main peak — but a pure wrong molecule still looks clean. Confirming identity requires mass spectrometry against the expected molecular weight.
- Why is amino acid analysis needed if HPLC shows high purity?
- Because purity is a ratio and peptide content is an absolute. A vial can be 99% pure and still contain less peptide than labelled, with the balance being counter-ion and residual water. AAA is what quantifies that.
- What does mass spec prove about a peptide?
- That the molecular weight of the material matches the intended sequence. It confirms identity and catches deletion sequences and wrong products; it does not tell you what fraction of the vial is that molecule.
Compounds discussed in this guide
More on quality control
- Cloudy, clumped or undissolved — diagnosing a failed reconstitutionFour appearances, four different causes. What a hazy vial, a gel, floating strands or a stubborn cake each tell you about the material and the technique.
- What the published safety record actually saysReported adverse effects, and the much more important fact of how little controlled human data exists behind them. What is documented, what is self-reported, and what has never been studied.
- A Certificate of Analysis in your name — what it coversA re-issued COA changes whose letterhead the data appears on. It does not change the data, the lot, or who performed the analysis — and claiming otherwise is where operators get into trouble.
All products discussed in this guide are supplied by Bench Grade Peptides for laboratory research use only. Not for human or veterinary use.




